HAEMONETICS CORP — Director's Dealing 2010

Mar 26, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-03-25

Reporting Person: NUTTER BRAD (Director, Chairman of the Board)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-25	Common Stock	M	26872	$41.15	Acquired	36259	Direct
2010-03-25	Common Stock	S	26872	$57.001	Disposed	9387	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-25	Non-Qualified Stock Option (right to buy)	$41.15	M	26872	Disposed	2012-07-27	Common Stock (26872)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$52.76	2013-05-05	Common Stock (200000)	200000	Direct
Non-Qualified Stock Option (right to buy)	$54.55	2015-10-22	Common Stock (64324)	64324	Direct
Non-Qualified Stock Option (right to buy)	$59.44	2016-07-30	Common Stock (5879)	5879	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan.

F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.

F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

F4: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.